Cargando…
Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma
BACKGROUND: Mesenchymal chondrosarcoma is an exceedingly rare malignancy, accounting for around 5% of all patients with chondrosarcoma. It is a translocation-related sarcoma that tends to have both local and distant recurrences. Surgery is the mainstay of treatment in localised cases however treatme...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453529/ https://www.ncbi.nlm.nih.gov/pubmed/32864096 http://dx.doi.org/10.1186/s13569-020-00138-4 |